NCT03626207View on ClinicalTrials.gov

Development of Visual Function Evaluation Method (2)

CompletedOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

October 4, 2018

Primary Completion Date

June 26, 2019

Study Completion Date

June 26, 2019

Conditions
Retinitis Pigmentosa
Trial Locations (1)

Unknown

Site JP00001, Kobe

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT03626207 - Development of Visual Function Evaluation Method (2) | Biotech Hunter | Biotech Hunter